|
Index of reports
> Cases resulting in life threatening events (14)
> Cases with Stevens-Johnson Syndrome (8)
Below is the selection of adverse event reports related to Esidrix (Hydrochlorothiazide) that includes cases resulting in life threatening events where reactions include stevens-johnson syndrome.
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a physician from France on 2007-07-09
Patient: 79 year old female
Adverse reactions / side effects: General Physical Condition Abnormal, Lupus-Like Syndrome, Fall, Periorbital Haematoma, Loss of Consciousness, Proteinuria, Depression, Sjogren's Syndrome, Renal Failure Acute, Prurigo, Stevens-Johnson Syndrome, White Blood Cell Count Decreased, Biopsy Salivary Gland Abnormal, Hyponatraemia, Staphylococcal Sepsis, Antinuclear Antibody Positive, Conjunctivitis Infective, Rash Erythematous, Dehydration, Asthenia, Anti-SS-A Antibody Positive, Face Injury
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Desloratadine
Dosage: 5 mg; qd; po
Administration route: Oral
Start date: 2006-06-15
End date: 2006-06-19
Arcalion (NO Pref. Name)
Dosage: po
Administration route: Oral
Start date: 2006-06-01
End date: 2006-06-19
Esidrix
End date: 2006-06-19
Primperan TAB
End date: 2006-06-19
Fluconazole
End date: 2006-06-19
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a individual with unspecified qualification from France on 2007-05-29
Patient: 79 year old female
Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Conjunctivitis, Pyrexia, Hypernatraemia, Fall, Loss of Consciousness, Periorbital Haematoma, C-Reactive Protein Increased, Proteinuria, Blood Uric Acid Increased, Dermatitis Bullous, Injury, Erythema Multiforme, Sjogren's Syndrome, Renal Failure Acute, Stevens-Johnson Syndrome, General Physical Health Deterioration, Staphylococcal Sepsis, Epidermolysis, Antinuclear Antibody Positive, Fluid Replacement, Dehydration, Rash Erythematous, Toxic Skin Eruption, Anti-SS-A Antibody Positive, Inflammation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Arcalion
Dosage: unk, unk
Administration route: Oral
Indication: Depressive Symptom
Start date: 2006-06-01
End date: 2006-06-19
Primperan INJ
End date: 2006-06-19
Triflucan
End date: 2006-06-19
Desloratadine
Dosage: 1 df, qd
Administration route: Oral
Start date: 2006-06-15
End date: 2006-06-19
Esidrix
Dosage: unk, unk
Administration route: Oral
End date: 2006-06-19
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-04
Patient: 79 year old female
Adverse reactions / side effects: Sepsis, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event
Suspect drug(s):
Triflucan
Start date: 2006-06-16
End date: 2006-06-19
Arcalion
Administration route: Oral
Start date: 2006-06-01
End date: 2006-06-19
Primperan INJ
Start date: 2006-06-19
End date: 2006-06-19
Desloratadine
Administration route: Oral
Start date: 2006-06-15
End date: 2006-06-19
Esidrix
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a physician from France on 2007-05-04
Patient: 79 year old female
Adverse reactions / side effects: Fall, Loss of Consciousness, Proteinuria, Blood Uric Acid Increased, Eyelid Disorder, Depression, Sjogren's Syndrome, Erythema Multiforme, Haematoma, Renal Failure Acute, Stevens-Johnson Syndrome, White Blood Cell Count Decreased, Toxic Epidermal Necrolysis, Hyponatraemia, Staphylococcal Sepsis, Epidermolysis, Antinuclear Antibody Positive, Conjunctivitis Infective, Sialoadenitis, Dehydration, Asthenia, Anti-SS-A Antibody Positive, Face Injury, Toxic Skin Eruption
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Desloratadine
Dosage: 5 mg; qd; po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-15
End date: 2006-06-19
Arcalion (NO Pref. Name)
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-01
End date: 2006-06-19
Esidrix
Indication: Drug USE FOR Unknown Indication
End date: 2006-06-19
Primperan TAB
Indication: Drug USE FOR Unknown Indication
End date: 2006-06-19
Fluconazole
Indication: Drug USE FOR Unknown Indication
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a individual with unspecified qualification from France on 2007-04-11
Patient: 79 year old female
Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Sodium Retention, Staphylococcal Sepsis, Fall, Loss of Consciousness, Proteinuria, Rash Erythematous, Dermatitis Bullous, Injury, Sjogren's Syndrome, Toxic Skin Eruption, Renal Failure Acute, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Arcalion
Dosage: unk, unk
Administration route: Oral
Start date: 2006-05-01
Primperan INJ
Triflucan
Desloratadine
Esidrix
Administration route: Oral
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-11
Patient: 79 year old female
Adverse reactions / side effects: Sepsis, Staphylococcal Sepsis, Stevens-Johnson Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event
Suspect drug(s):
Triflucan
Arcalion
Administration route: Oral
Primperan INJ
Desloratadine
Esidrix
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a individual with unspecified qualification from France on 2007-03-09
Patient: 79 year old female
Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Fall, Loss of Consciousness, Rash Erythematous, Dermatitis Bullous, Injury, Sjogren's Syndrome, Toxic Skin Eruption, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Arcalion
Dosage: unk, unk
Administration route: Oral
Start date: 2006-05-01
Primperan INJ
Triflucan
Desloratadine
Esidrix
Administration route: Oral
Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)
Reported by a physician from France on 2007-03-05
Patient: 79 year old female
Adverse reactions / side effects: Systemic Lupus Erythematosus, Sjogren's Syndrome, Fall, Face Injury, Loss of Consciousness, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Desloratadine
Dosage: po
Administration route: Oral
Arcalion (NO Pref. Name)
Dosage: po
Administration route: Oral
Esidrix
Primperan TAB
Trifulcan (Fluconazole)
Indication: Drug USE FOR Unknown Indication
|
